Cycorium Cyclophosphamide Tablet 50mg

Back to Medicines
Cycorium Cyclophosphamide Tablet 50mg, image 1

Quality Assurance & Dispatch

WHO-GMP Standard
Cold Chain Logistics
Hospital Procurement
Pan-India Supply
OncologyOncologyN/AIn StockRx Prescription Only

Cycorium Cyclophosphamide Tablet 50mg

Brand: CycoriumSKU: ONC77
Maximum Retail Price (MRP)
₹24.15(Inclusive of all taxes)
Bulk Hospital Pricing on Enquiry

Product Summary

Cycorium Cyclophosphamide Tablets 50 mg is a prescription oral cytotoxic chemotherapy medicine containing a stated 50 mg of Cyclophosphamide per tablet.

Dosage FormN/A
Therapy AreaN/A
PackagingN/A
CategoryOncology
Quantity:
1
Proceed to Checkout

Cycorium Cyclophosphamide Tablets 50 mg is a prescription oral oncology medicine identified as containing Cyclophosphamide 50 mg per tablet.

Cyclophosphamide is a cytotoxic anticancer medicine classified as an alkylating agent.

It is a prodrug that is activated in the liver to metabolites that damage DNA and interfere with cell replication.

Cyclophosphamide is used in selected treatment regimens for lymphomas, leukemias, breast cancer and other malignancies.

It also has established uses in certain non-oncology conditions under specialist supervision, depending on the formulation and applicable approvals.

IMPORTANT SAFETY WARNINGCyclophosphamide can cause severe myelosuppression, serious infections, hemorrhagic cystitis, infertility, secondary malignancies and embryo-fetal toxicity.

The stated 50 mg tablet strength does not establish the prescribed daily dose. Dosing varies considerably according to the indication, treatment protocol, body surface area, kidney and liver function, and treatment tolerance.

The exact manufacturer, pack size, tablet composition, storage conditions and approved indications of Cycorium must be verified from its approved Indian product documentation.

Marketed by Essentials Emporium Enterprises, Cycorium is listed within the oncology pharmaceutical category for hospitals, cancer treatment centres and authorized pharmaceutical buyers.

Key Product Features

Brand NameCycorium
Generic NameCyclophosphamide
Stated Strength50 mg
Dosage FormTablet
Therapeutic CategoryOncology
Drug ClassAlkylating Agent
Treatment TypeOral Cytotoxic Chemotherapy
MechanismDNA Cross-Linking Following Metabolic Activation
Reference UsesSelected Lymphoma, Leukemia, Breast Cancer and Other Malignancy Regimens
Administration RouteOral
Prescription StatusPrescription-only
Major Safety ConcernsMyelosuppression, Hemorrhagic Cystitis, Infertility and Secondary Malignancies
MonitoringBlood Counts, Urinalysis, Kidney Function and Treatment Tolerance